The Strain-Encoded Relationship between PrP Replication, Stability and Processing in Neurons is Predictive of the Incubation Period of Disease
Prion strains are characterized by differences in the outcome of disease, most notably incubation period and neuropathological features. While it is established that the disease specific isoform of the prion protein, PrPSc, is an essential component of the infectious agent, the strain-specific relationship between PrPSc properties and the biological features of the resulting disease is not clear. To investigate this relationship, we examined the amplification efficiency and conformational stability of PrPSc from eight hamster-adapted prion strains and compared it to the resulting incubation period of disease and processing of PrPSc in neurons and glia. We found that short incubation period strains were characterized by more efficient PrPSc amplification and higher PrPSc conformational stabilities compared to long incubation period strains. In the CNS, the short incubation period strains were characterized by the accumulation of N-terminally truncated PrPSc in the soma of neurons, astrocytes and microglia in contrast to long incubation period strains where PrPSc did not accumulate to detectable levels in the soma of neurons but was detected in glia similar to short incubation period strains. These results are inconsistent with the hypothesis that a decrease in conformational stability results in a corresponding increase in replication efficiency and suggest that glia mediated neurodegeneration results in longer survival times compared to direct replication of PrPSc in neurons.
Vyšlo v časopise:
The Strain-Encoded Relationship between PrP Replication, Stability and Processing in Neurons is Predictive of the Incubation Period of Disease. PLoS Pathog 7(3): e32767. doi:10.1371/journal.ppat.1001317
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001317
Souhrn
Prion strains are characterized by differences in the outcome of disease, most notably incubation period and neuropathological features. While it is established that the disease specific isoform of the prion protein, PrPSc, is an essential component of the infectious agent, the strain-specific relationship between PrPSc properties and the biological features of the resulting disease is not clear. To investigate this relationship, we examined the amplification efficiency and conformational stability of PrPSc from eight hamster-adapted prion strains and compared it to the resulting incubation period of disease and processing of PrPSc in neurons and glia. We found that short incubation period strains were characterized by more efficient PrPSc amplification and higher PrPSc conformational stabilities compared to long incubation period strains. In the CNS, the short incubation period strains were characterized by the accumulation of N-terminally truncated PrPSc in the soma of neurons, astrocytes and microglia in contrast to long incubation period strains where PrPSc did not accumulate to detectable levels in the soma of neurons but was detected in glia similar to short incubation period strains. These results are inconsistent with the hypothesis that a decrease in conformational stability results in a corresponding increase in replication efficiency and suggest that glia mediated neurodegeneration results in longer survival times compared to direct replication of PrPSc in neurons.
Zdroje
1. CastillaJ
SaaP
HetzC
SotoC
2005
In vitro generation of infectious scrapie prions.
Cell
121
195
206
2. DeleaultNR
HarrisBT
ReesJR
SupattaponeS
2007
Formation of native prions from minimal components in vitro.
Proc Natl Acad Sci U S A
104
9741
9746
3. PrusinerSB
1982
Novel proteinaceous infectious particles cause scrapie.
Science
216
136
144
4. WangF
WangX
YuanCG
MaJ
2010
Generating a prion with bacterially expressed recombinant prion protein.
Science
327
1132
1135
5. MakaravaN
KovacsGG
BocharovaO
SavtchenkoR
AlexeevaI
2010
Recombinant prion protein induces a new transmissible prion disease in wild-type animals.
Acta Neuropathol
119
177
187
6. SigurdsonCJ
NilssonKP
HornemannS
HeikenwalderM
MancoG
2009
De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.
Proc Natl Acad Sci U S A
106
304
309
7. HoriuchiM
PriolaSA
ChabryJ
CaugheyB
2000
Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
Proc Natl Acad Sci U S A
97
5836
5841
8. PrusinerSB
ScottM
FosterD
PanKM
GrothD
1990
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.
Cell
63
673
686
9. WeissmannC
1991
A ‘unified theory’ of prion propagation [see comments].
Nature
352
679
683
10. CaugheyBW
DongA
BhatKS
ErnstD
HayesSF
1991
Secondary structure analysis of the scrapie-associated protein PrP 27–30 in water by infrared spectroscopy [published erratum appears in Biochemistry 1991 Oct 29;30(43):10600].
Biochemistry
30
7672
7680
11. PanKM
BaldwinM
NguyenJ
GassetM
SerbanA
1993
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.
Proc Natl Acad Sci U S A
90
10962
10966
12. FraserH
DickinsonAG
1968
The sequential development of the brain lesion of scrapie in three strains of mice.
J Comp Pathol
78
301
311
13. CollingeJ
ClarkeAR
2007
A general model of prion strains and their pathogenicity.
Science
318
930
936
14. BartzJC
DejoiaC
TuckerT
KincaidAE
BessenRA
2005
Extraneural prion neuroinvasion without lymphoreticular system infection.
J Virol
79
11858
11863
15. BessenRA
MarshRF
1994
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy.
J Virol
68
7859
7868
16. DeArmondSJ
SanchezH
YehielyF
QiuY
Ninchak-CaseyA
1997
Selective neuronal targeting in prion disease.
Neuron
19
1337
1348
17. MahalSP
BakerCA
DemczykCA
SmithEW
JuliusC
2007
Prion strain discrimination in cell culture: the cell panel assay.
Proc Natl Acad Sci U S A
104
20908
20913
18. GreilCS
VorbergIM
WardAE
Meade-WhiteKD
HarrisDA
2008
Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.
Virology
379
284
293
19. MagalhaesAC
BaronGS
LeeKS
Steele-MortimerO
DorwardD
2005
Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells.
J Neurol Sci
25
5207
5216
20. KarapetyanYE
SaaP
MahalSP
SferrazzaGF
ShermanA
2009
Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay.
PLoS One
4
e5730
21. AyersJI
KincaidAE
BartzJC
2009
Prion strain targeting independent of strain-specific neuronal tropism.
J Virol
83
81
87
22. CaugheyB
RaymondGJ
BessenRA
1998
Strain-dependent differences in beta-sheet conformations of abnormal prion protein.
J Biol Chem
273
32230
32235
23. KascsakRJ
RubensteinR
MerzPA
CarpRI
RobakisNK
1986
Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains.
J Virol
59
676
683
24. LegnameG
NguyenHO
PeretzD
CohenFE
DeArmondSJ
2006
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.
Proc Natl Acad Sci U S A
103
19105
19110
25. SafarJ
WilleH
ItriV
GrothD
SerbanH
1998
Eight prion strains have PrP(Sc) molecules with different conformations [see comments].
Nature Med
4
1157
1165
26. TellingGC
ParchiP
DeArmondSJ
CortelliP
MontagnaP
1996
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity [see comments].
Science
274
2079
2082
27. PeretzD
ScottMR
GrothD
WilliamsonRA
BurtonDR
2001
Strain-specified relative conformational stability of the scrapie prion protein.
Prot Sci
10
854
863
28. TixadorP
HerzogL
ReineF
JaumainE
ChapuisJ
2010
The physical relationship between infectivity and prion protein aggregates is strain-dependent.
PLoS Pathog
6
e1000859
29. ColbyDW
GilesK
LegnameG
WilleH
BaskakovIV
2009
Design and construction of diverse mammalian prion strains.
Proc Natl Acad Sci U S A
106
20417
20422
30. WilleH
BianW
McDonaldM
KendallA
ColbyDW
2009
Natural and synthetic prion structure from X-ray fiber diffraction.
Proc Natl Acad Sci U S A
106
16990
16995
31. MaselJ
JansenVA
NowakMA
1999
Quantifying the kinetic parameters of prion replication.
Biophys Chem
77
139
152
32. SilveiraJR
RaymondGJ
HughsonAG
RaceRE
SimVL
2005
The most infectious prion protein particles.
Nature
437
257
261
33. TanakaM
CollinsSR
ToyamaBH
WeissmanJS
2006
The physical basis of how prion conformations determine strain phenotypes.
Nature
442
585
589
34. KryndushkinDS
AlexandrovIM
Ter-AvanesyanMD
KushnirovVV
2003
Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104.
J Biol Chem
278
49636
49643
35. GonzalezL
MartinS
Begara-McGorumI
HunterN
HoustonF
2002
Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie.
J Comp Pathol
126
17
29
36. JeffreyM
MartinS
GonzâalezL
2003
Cell-associated variants of disease-specific prion protein immunolabelling are found in different sources of sheep transmissible spongiform encephalopathy.
J Gen Virol
84
1033
1045
37. JeffreyM
GoodsirCM
RaceRE
ChesebroB
2004
Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
Ann Neurol
55
781
792
38. MallucciG
DickinsonA
LinehanJ
KlohnPC
BrandnerS
2003
Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.
Science
302
871
874
39. MallucciGR
WhiteMD
FarmerM
DickinsonA
KhatunH
2007
Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.
Neuron
53
325
335
40. GreenKM
CastillaJ
SewardTS
NapierDL
JewellJE
2008
Accelerated high fidelity prion amplification within and across prion species barriers.
PLoS Pathog
4
e1000139
41. LeeS
FernandezEJ
GoodTA
2007
Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway.
Prot Sci
16
723
732
42. SunY
MakaravaN
LeeCI
LaksanalamaiP
RobbFT
2008
Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size.
J Mol Biol
376
1155
1167
43. XueWF
HellewellAL
GosalWS
HomansSW
HewittEW
2009
Fibril fragmentation enhances amyloid cytotoxicity.
J Biol Chem
284
34272
34282
44. YonetaniM
NonakaT
MasudaM
InukaiY
OikawaT
2009
Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant.
J Biol Chem
284
7940
7950
45. ZhouZ
FanJB
ZhuHL
ShewmakerF
YanX
2009
Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding.
J Biol Chem
284
30148
30158
46. PeretzD
SupattaponeS
GilesK
VergaraJ
FreymanY
2006
Inactivation of prions by acidic sodium dodecyl sulfate.
J Virol
80
322
331
47. PrusinerSB
GrothD
SerbanA
StahlN
GabizonR
1993
Attempts to restore scrapie prion infectivity after exposure to protein denaturants.
Proc Natl Acad Sci U S A
90
2793
2797
48. RiesnerD
KellingsK
PostK
WilleH
SerbanH
1996
Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.
J Virol
70
1714
1722
49. ShikiyaRA
AyersJI
SchuttCR
KincaidAE
BartzJC
2010
Co-infecting prion strains compete for a limiting cellular resource.
J Virol
84
5706
5714
50. MulcahyER
BessenRA
2004
Strain-specific kinetics of prion protein formation in vitro and in vivo.
J Biol Chem
279
1643
1649
51. GhaemmaghamiS
AhnM
LessardP
GilesK
LegnameG
2009
Continuous quinacrine treatment results in the formation of drug-resistant prions.
PLoS Pathog
5
e1000673
52. LiJ
BrowningS
MahalSP
OelschlegelAM
WeissmannC
2009
Darwinian evolution of prions in cell culture.
Science
327
869
872
53. ChenSG
TeplowDB
ParchiP
TellerJK
GambettiP
1995
Truncated forms of the human prion protein in normal brain and in prion diseases.
J Biol Chem
270
19173
19180
54. DronM
MoudjouM
ChapuisJ
SalamatMK
BernardJ
2010
Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent.
J Biol Chem
285
10252
10264
55. Jimenez-HueteA
LievensPM
VidalR
PiccardoP
GhettiB
1998
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.
Am J Pathol
153
1561
1572
56. YadavalliR
GuttmannRP
SewardT
CentersAP
WilliamsonRA
2004
Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
J Biol Chem
279
21948
21956
57. KercherL
FavaraC
ChanCC
RaceR
ChesebroB
2004
Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.
Am J Pathol
165
2055
2067
58. BessenRA
MarshRF
1992
Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters.
J Gen Virol
73
329
334
59. WilsonMI
McBrideP
2000
Technical aspects of tracking scrapie infection in orally dosed rodents.
J Cell Pathol
5
17
22
60. KramerML
BartzJC
2009
Rapid, high-throughput detection of PrP(Sc) by 96-well immunoassay.
Prion
3
44
48
61. GonzalezL
MartinS
JeffreyM
2003
Distinct profiles of PrP(d) immunoreactivity in the brain of scrapie- and BSE-infected sheep: implications for differential cell targeting and PrP processing.
J Gen Virol
84
1339
1350
62. KimberlinRH
WalkerC
1977
Characteristics of a short incubation model of scrapie in the golden hamster.
J Gen Virol
34
295
304
63. BartzJC
MarshRF
McKenzieDI
AikenJM
1998
The host range of chronic wasting disease is altered on passage in ferrets.
Virology
251
297
301
64. KimberlinRH
WalkerCA
FraserH
1989
The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice.
J Gen Virol
70
2017
2025
65. YuS
YinS
LiC
WongP
ChangB
2007
Aggregation of prion protein with insertion mutations is proportional to the number of inserts.
Biochem J
403
343
351
66. ManserJ
MassonW
JonesP
BostockC
2002
TSE Resource Centre and generation of monoclonal antibodies to recombinant ovine PrP (residues Met 23–230) in 129/Ola PrP null mice [abstract P3.16].
In: International Conference on Transmissible Spongiform Encephalopathies; 15–18 September 2002; Edinburgh, United Kingdom
67. PolymenidouM
MoosR
ScottM
SigurdsonC
ShiYZ
2008
The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.
PLoS ONE
3
e3872
68. KascsakRJ
RubensteinR
MerzPA
Tonna-DeMasiM
FerskoR
1987
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.
J Virol
61
3688
3693
69. KorthC
StierliB
StreitP
MoserM
SchallerO
1997
Prion (PrPSc)-specific epitope defined by a monoclonal antibody.
Nature
390
74
77
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 3
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- A Toxin that Hijacks the Host Ubiquitin Proteolytic System
- Invasive Extravillous Trophoblasts Restrict Intracellular Growth and Spread of
- Blood Meal-Derived Heme Decreases ROS Levels in the Midgut of and Allows Proliferation of Intestinal Microbiota
- Metabolite Cross-Feeding Enhances Virulence in a Model Polymicrobial Infection